Use of convalescent plasma in pregnant women with early stage COVID-19 infection in a tertiary care hospital in Dubai, February to March 2021: a case series study

Table 2 Convalescent plasma units titer levels

Case no.	CCP date	COV-2 IgG^a (Qualitative) *1st unit*	COV-2IgGII^a (Quantitative) *1st unit*	COV-2 IgG^a (Qualitative) *2nd unit*	COV-2IgGII^a (Quantitative) *2nd unit*
1	15/02/21 & 16/02/21	2.4	44.9 AU/mL	0.13	131.8 AU/mL
2	14/02/2021 & 15/02/2021	1.4	416.8 AU/mL	0.02	1.1 AU/mL
3	18/02/21 & 19/02/2021	1.9	579.1 AU/mL	Received only 1 unit	Received only 1 unit
4	17/02/2021	2.3	355.4 AU/mL	Received only 1 unit	Received only 1 unit
5	24/02/2021 & 26/02/2021	2.3	355.4 AU/ml	5.98	2726.9 AU/mL
6	26/02/2021 & 27/02/2021	5.29	1828.6 AU/mL	6.15	14,960.8 AU/mL
7	01/03/2021 & 03/03/2021	5.26	12,276.4 AU/mL	5.26	12,276.4 AU/mL

^a FDA high titre on qualitative Index (S/C) ≥ 4.5 and on quantitative test ≥840 AU/mL [17]

ISSN: 1471-2393